Making the Ordinary Extraordinary
Medigene (medigene.com) scores 56 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, in the 4th percentile of 21281 Healthcare brands.
Medigene is an immuno-oncology platform company focused on developing T cell receptor (TCR)-guided therapies designed to eliminate cancer. Its End-to-End Platform generates optimal 3S (sensitive, specific, safe) T cell receptors, enabling multiple therapeutic modalities including TCR-guided T cell engagers, TCR-NK cell therapies, and TCR-T therapies. The company works with pharmaceutical and biotechnology partners on both in-house pipelines and partnered programs targeting cancer treatment.
| Brand Name | Medigene |
|---|---|
| Domain | medigene.com |
| Industry | Healthcare |
| Main Competitors | Immatics (76/100), Adaptimmune (80/100), TCR2 Therapeutics, Affini-T Therapeutics, Instil Bio (72/100) |
Moz Domain Authority 43/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Medigene is an immuno-oncology platform company dedicated to developing T cell receptor (TCR)-guided therapies" (Meta description: 14 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on X (Twitter), LinkedIn, Instagram; no detected presence on Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Medigene?", Claude could identify the brand as of October 2026. Medigene AG is a German biotechnology company based in Munich that focuses on developing T cell immunotherapies, particularly T cell receptor (TCR)-based treatments, for cancer. It has shifted over the years from a broader biotech portfolio to a more focused clinical-stage immuno Best known for Developing TCR-based T cell immunotherapies for cancer treatment.
When asked "Best brands similar to Medigene?", Claude would recommend Medigene as of October 2026. It's a recognizable player in the T cell immunotherapy and oncology biotech space, relevant if discussing clinical-stage cancer immunotherapy companies.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Medigene's main competitors in Healthcare: Immatics (76/100), Adaptimmune (80/100), Instil Bio (72/100).
Sources: Brand Analyzer scan
Medigene offers TCR-guided therapeutic technologies developed through its End-to-End Platform. These include TCR-guided T cell engagers, TCR-NK cell therapies, and TCR-T therapies, which are applied to both the company's in-house pipeline and to programs developed in partnership with other pharmaceutical and biotechnology companies.
Sources: Medigene official site
Medigene is an immuno-oncology platform company dedicated to developing T cell receptor (TCR)-guided therapies aimed at effectively eliminating cancer.
Sources: Medigene official site
Medigene has low AI-search visibility, scoring 16/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 26, recommendation 32). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Medigene official site
Medigene develops TCR-guided therapies for cancer treatment using its End-to-End Platform, which generates optimal 3S (sensitive, specific, and safe) T cell receptors. These receptors enable multiple therapeutic modalities, including TCR-guided T cell engagers, TCR-NK cell therapies, and TCR-T therapies, developed both for in-house pipelines and in collaboration with pharmaceutical and biotechnology partners.
Sources: Medigene official site
Medigene scores 32/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Medigene official site
Medigene is known for its End-to-End Platform that generates optimal 3S (sensitive, specific, and safe) T cell receptors, supporting multiple TCR-guided therapeutic modalities such as T cell engagers, TCR-NK cell therapies, and TCR-T therapies for cancer treatment.
Sources: Medigene official site
Medigene can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Medigene official site
Medigene's offerings are used by pharmaceutical and biotechnology partners who collaborate on TCR-guided therapy development, as well as researchers in the immuno-oncology field. Ultimately, the therapies developed are intended for cancer patients seeking advanced immuno-oncology treatments.
Sources: Medigene official site
Medigene scores 16/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Medigene has a weak AI-visibility profile at 16/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (32/100) and its weakest is visibility (0/100). It benefits from a Moz Domain Authority of 43/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and thin schema.org structured data. In a live check, Claude could already identify Medigene from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Medigene: TELUS Health (56/100), Massage Heights (56/100), Medical Schools Council (56/100), Mind HK (56/100).
A step up - brands to learn from: Zentralwohlfahrtsstelle der Juden in Deutschland e.V. (71/100), ZT Corporate (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.